Acino, a Swiss-based pharmaceutical company, develops, manufactures and internationally markets well-proven and innovative pharmaceuticals in novel drug delivery forms. Acino specializes in advanced drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. As a partner of pharmaceutical companies worldwide, Acino supplies finished in-house developed products and/or provide...Show all

Acino, a Swiss-based pharmaceutical company, develops, manufactures and internationally markets well-proven and innovative pharmaceuticals in novel drug delivery forms. Acino specializes in advanced drug delivery technologies with a focus on modified...Show all

Company (Alive / Active)

Phone: +41 44 555 22 00

Fax:

Thurgauerstrasse 36/38

Zurich, 8050
Switzerland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Acino $0M Oct 2, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Acino Jobs

jobs by Indeed job
						search

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Device for the manufacture of pharmaceutical patches Jul 01, 2015 Sep 01, 2020 Patent
Lattice loss reduction Jan 21, 2013 Sep 01, 2020 Patent
Transdermal therapeutic system for administering rivastigmine or derivatives thereof Dec 19, 2014 Sep 18, 2018 Patent
Application aid Aug 03, 2012 Sep 13, 2016 Patent
Transdermal therapeutic system for administering rivastigmine or derivatives thereof Dec 14, 2010 Feb 24, 2015 Patent
See all 8 patents